Skip to main content
BrainCited

Uridine Monophosphate für Neurotransmitter Imbalance

C

The uridine + DHA + choline combination (known as the 'Mr. Happy Stack') provides synergistic support for phospholipid synthesis and dopamine receptor expression. Limited but promising clinical evidence.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Duridine\u002Dmonophosphate\u0026condition\u003Dneurotransmitter\u002Dimbalance'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

Fazit

The uridine + DHA + choline combination (known as the 'Mr. Happy Stack') provides synergistic support for phospholipid synthesis and dopamine receptor expression. Limited but promising clinical evidence.

Key Study Findings

Observational Study
Combining Metabolomics and Proteomics to Reveal Key Serum Compounds Related to Canine Intervertebral Disc Herniation.
Dose: None vs.: None Outcome: None Wirkung: None None

Population: Dogs with intervertebral disc herniation

In Vitro
The Effects of Semen Ziziphi Spinosae Extract on LPS-Induced Astrocyte Gene Expression and Metabolites.
Dose: None vs.: LPS-treated astrocyte controls Outcome: Astrocyte gene expression and metabolite changes Wirkung: None None

Population: LPS-induced inflammatory astrocyte model

Review
Involvement of uridine in brain and gut health: insights into its neuroprotective potential via the …
Dose: None vs.: None Outcome: None Wirkung: None None

Population: None

Other
1H and 31P magnetic resonance spectroscopy reveals potential pathogenic and biomarker metabolite alterations in Lafora …
Dose: None vs.: None Outcome: None Wirkung: None P = 0.013

Population: Healthy adults

Other 4 weeks
Jujuboside A Regulates Calcium Homeostasis and Structural Plasticity to Alleviate Depression-Like Behavior via Shh Signaling …
Dose: 5 mg/kg vs.: None Outcome: Cognitive function Wirkung: None None

Population: Sprague Dawley rats

Key Statistics

4

Studien

300

Teilnehmer

Positive

C

Bewertung

Referenced Papers

Aging and disease 2023 9 Zitierungen
Clinical pharmacokinetics 2018 128 Zitierungen
Autonomic neuroscience : … 2015 81 Zitierungen
European journal of … 2011 16 Zitierungen
Annual review of … 2009 141 Zitierungen
The European journal … 2007 55 Zitierungen
Molecular and chemical … 1996 17 Zitierungen
Journal of neuroscience … 1996 16 Zitierungen
Behavioural brain research 1995 146 Zitierungen
Journal of steroid … 1984 22 Zitierungen

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Übliche Dosierungen

general:
150-250 mg/day
cognitivesupport:
250-500 mg sublingually

Obergrenze: Not established; well-tolerated up to 1,000 mg/day

In der Forschung untersuchte Dosierungen

Dosierung Dauer Wirkung N
None -- Mixed --
None -- Positive --
None -- Mixed --
None -- Neutral --
5 mg/kg 4 weeks Positive --
1 g -- Mixed --
None -- Mixed --
None -- Mixed --

Beste Einnahmezeit: Morning; synergizes with DHA and choline sources

Safety & Side Effects

Gemeldete Nebenwirkungen

  • Mild gastrointestinal discomfort
  • Headache (rare)
  • Nervousness at high doses

Bekannte Wechselwirkungen

  • No significant drug interactions established

Tolerierbare Höchstaufnahmemenge: Not established; well-tolerated up to 1,000 mg/day

Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.

Frequently Asked Questions

Does Uridine Monophosphate help with Neurotransmitter Imbalance?
Based on 4 studies with 300 participants, there is limited but promising evidence that Uridine Monophosphate may support Neurotransmitter Imbalance management. Our evidence grade is C (Some Evidence).
How much Uridine Monophosphate should I take for Neurotransmitter Imbalance?
Studies have used various dosages. A commonly studied range is 150-250 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Uridine Monophosphate?
Reported side effects may include Mild gastrointestinal discomfort, Headache (rare), Nervousness at high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Uridine Monophosphate and Neurotransmitter Imbalance?
We rate the evidence as Grade C (Some Evidence). This rating is based on 4 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

Related Evidence

Andere Inhaltsstoffe für Neurotransmitter Imbalance

FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.